EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cannabidiol in Dietary Supplements: Characteristics, Routes of Administration, Bioavailability, and Research Challenges

Angelika Talar-Śpionek, Edyta Juszczuk-Kubiak iD, Marek Roszko iD

Molecules · 2026

DOI: 10.3390/molecules31132385 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2026. Verfasst von Angelika Talar-Śpionek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Safety and Chemical Analysis, Prof. Wacław Dąbrowski Institute of Agricultural and Food Biotechnology-State Research Institute, 36…. Hauptthemen laut MEDLINE: Cannabidiol, Dietary Supplements. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education, Ministry of Science and Higher Education, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabidiol (CBD) has gained increasing attention as an ingredient in dietary supplements and functional foods due to its potential health-promoting properties. As a major non-psychoactive phytocannabinoid derived from Cannabis sativa L., CBD has been associated with anti-inflammatory, antioxidant, and neuroprotective effects. However, its application in nutraceutical products remains challenging because of its low and variable oral bioavailability, limited long-term safety data, and ongoing regulatory requirements. In the European Union (EU), CBD-containing products are classified as Novel Foods and require a comprehensive safety assessment before market authorisation. This review summarises current knowledge on CBD in dietary supplements, providing an overview of its chemical characteristics, routes of administration, and the key factors influencing its absorption and pharmacokinetics. It also reviews the main CBD formulations available in dietary supplements, including oils, capsules, gummies, and e-liquids, with particular emphasis on their characteristics relevant to CBD stability and bioavailability, as well as current regulatory frameworks. Finally, the major scientific and technological challenges associated with CBD-containing dietary supplements are highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolDietary SupplementsBiological AvailabilityHumansAnimalsCannabis

Stichwörter der Autor:innen

bioavailabilitycannabidiol (CBD)dietary supplementsnovel foodssafety

Substanzen

Cannabidiol

Autor:innen und Institutionen

  • Department of Food Safety and Chemical Analysis, Prof. Wacław Dąbrowski Institute of Agricultural and Food Biotechnology-State Research Institute, 36 Rakowiecka Street, 02-532 Warsaw, Poland.
  • Department of Biotechnology, Prof. Wacław Dąbrowski Institute of Agricultural and Food Biotechnology-State Research Institute, 36 Rakowiecka Street, 02-532 Warsaw, Poland.

ORCID-Profile: Edyta Juszczuk-Kubiak, Marek Roszko

Förderung

  • Ministry of Science and Higher Education
  • Ministry of Science and Higher Education, Poland

Zitieren

APA

Talar-Śpionek, A., Juszczuk-Kubiak, E., & Roszko, M. (2026). Cannabidiol in Dietary Supplements: Characteristics, Routes of Administration, Bioavailability, and Research Challenges. Molecules. https://doi.org/10.3390/molecules31132385

Vancouver

Talar-Śpionek A, Juszczuk-Kubiak E, Roszko M. Cannabidiol in Dietary Supplements: Characteristics, Routes of Administration, Bioavailability, and Research Challenges. Molecules. 2026. doi:10.3390/molecules31132385

BibTeX
@article{Talarpionek2026,
  author = {Talar-Śpionek, Angelika and Juszczuk-Kubiak, Edyta and Roszko, Marek},
  title = {Cannabidiol in Dietary Supplements: Characteristics, Routes of Administration, Bioavailability, and Research Challenges},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31132385}
}
Kostenlos starten →